Skip to content
10-Q

Quarterly Report

HAEMONETICS CORPORATION HAE

0000313143-25-000075

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Oct 31, 2025 46.81M sh
Shares Diluted Q2 2026 · Sep 27, 2025 47.66M sh
Shares Diluted Q2 2026 · Sep 27, 2025 48.01M sh
Shares Diluted Q2 2026 · Sep 28, 2024 51.24M sh
Shares Diluted Q2 2026 · Sep 28, 2024 51.4M sh
Stock Repurchased Q2 2026 · Sep 27, 2025 $75M
Stock Repurchased Q2 2026 · Sep 28, 2024 $75M
Capex Q2 2026 · Sep 27, 2025 $8.77M
Capex Q2 2026 · Sep 28, 2024 $15.09M
Operating Cash Flow Q2 2026 · Sep 27, 2025 $128.72M
Operating Cash Flow Q2 2026 · Sep 28, 2024 $21.4M
Long Term Debt Q2 2026 · Sep 27, 2025 $920.39M
Long Term Debt Q2 2026 · Mar 29, 2025 $921.23M
Cash And Equivalents Q2 2026 · Sep 27, 2025 $296.43M
Cash And Equivalents Q2 2026 · Mar 29, 2025 $306.76M
Stockholders Equity Q2 2026 · Sep 27, 2025 $849.17M
Stockholders Equity Q2 2026 · Jun 28, 2025 $882.3M
Stockholders Equity Q2 2026 · Mar 29, 2025 $820.84M
Stockholders Equity Q2 2026 · Sep 28, 2024 $878.85M
Stockholders Equity Q2 2026 · Jun 29, 2024 $905.37M
Stockholders Equity Q2 2026 · Mar 30, 2024 $959.96M
Current Liabilities Q2 2026 · Sep 27, 2025 $548.32M
Current Liabilities Q2 2026 · Mar 29, 2025 $578.11M
Current Assets Q2 2026 · Sep 27, 2025 $899.68M
Current Assets Q2 2026 · Mar 29, 2025 $934.98M
Total Assets Q2 2026 · Sep 27, 2025 $2.44B
Total Assets Q2 2026 · Mar 29, 2025 $2.45B
Eps Diluted Q2 2026 · Sep 27, 2025 $0.81
Eps Diluted Q2 2026 · Sep 27, 2025 $1.51
Eps Diluted Q2 2026 · Sep 28, 2024 $0.66
Eps Diluted Q2 2026 · Sep 28, 2024 $1.40
Eps Basic Q2 2026 · Sep 27, 2025 $0.81
Eps Basic Q2 2026 · Sep 27, 2025 $1.52
Eps Basic Q2 2026 · Sep 28, 2024 $0.66
Eps Basic Q2 2026 · Sep 28, 2024 $1.42
Sga Expense Q2 2026 · Sep 27, 2025 $101.62M
Sga Expense Q2 2026 · Sep 27, 2025 $212.33M
Sga Expense Q2 2026 · Sep 28, 2024 $106.95M
Sga Expense Q2 2026 · Sep 28, 2024 $215.19M
Rd Expense Q2 2026 · Sep 27, 2025 $14.87M
Rd Expense Q2 2026 · Sep 27, 2025 $31.13M
Rd Expense restated Q2 2026 · Sep 28, 2024 $14.14M
Rd Expense restated Q2 2026 · Sep 28, 2024 $28.59M
Net Income Q2 2026 · Sep 27, 2025 $38.68M
Net Income Q2 2026 · Sep 27, 2025 $72.72M
Net Income Q2 2026 · Jun 28, 2025 $34.03M
Net Income Q2 2026 · Sep 28, 2024 $33.83M
Net Income Q2 2026 · Sep 28, 2024 $72.2M
Net Income Q2 2026 · Jun 29, 2024 $38.37M
Operating Income Q2 2026 · Sep 27, 2025 $58.49M
Operating Income Q2 2026 · Sep 27, 2025 $112.36M
Operating Income Q2 2026 · Sep 28, 2024 $51.7M
Operating Income Q2 2026 · Sep 28, 2024 $91.45M
Gross Profit Q2 2026 · Sep 27, 2025 $194.74M
Gross Profit Q2 2026 · Sep 27, 2025 $386.99M
Gross Profit Q2 2026 · Sep 28, 2024 $187.44M
Gross Profit Q2 2026 · Sep 28, 2024 $362.36M
Cost Of Revenue Q2 2026 · Sep 27, 2025 $132.57M
Cost Of Revenue Q2 2026 · Sep 27, 2025 $261.72M
Cost Of Revenue Q2 2026 · Sep 28, 2024 $158.07M
Cost Of Revenue Q2 2026 · Sep 28, 2024 $319.32M
Revenue Q2 2026 · Sep 27, 2025 $327.32M
Revenue Q2 2026 · Sep 27, 2025 $648.71M
Revenue Q2 2026 · Sep 28, 2024 $345.51M
Revenue Q2 2026 · Sep 28, 2024 $681.68M